Christopher Mehlin David - 16 Jan 2024 Form 4 Insider Report for Novo Integrated Sciences, Inc. (NVOS)

Role: Chief Operating Officer, Director
Signature: /s/ Christopher David
Issuer symbol: NVOS
Transactions as of: 16 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 12 Sep 2024, 06:05:09 UTC
Previous filing: 02 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NOVO	Class A Common Stock						8,195	16 Jan 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NOVO	Stock Option (right to buy)	Award	$0	+200,000		$0.000000	200,000	16 Jan 2024	Common Stock	200,000	$0.7800	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant, by the issuer's Board of Directors, of an option to purchase 200,000 shares of the issuer's common stock at an exercise price of $0.78 per share. The option was fully vested and exercisable on the date of grant and is exercisable until January 16, 2030.